Moricizine
Back to searchMolecule Structure
Scientific Name
Moricizine
Description of the Drug
Moricizine is an antiarrhythmic used to treat arrhythmias.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00680
http://www.drugbank.ca/drugs/DB00680
Brand Name(s)
Ethmozine
Company Owner(s)
Shire Development Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Sodium channel alpha subunit | PROTEIN FAMILY | BLOCKER | CHEMBL2331043 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL16794 | |
| PharmGKB | PA164747738 | |
| Human Metabolome Database | HMDB0014818 | |
| DrugBank | DB00680 | |
| PubChem: Thomson Pharma | 14782938 | |
| PubChem | 34633 | |
| Mcule | MCULE-2907779244 | |
| LINCS | LSM-2476 | |
| Nikkaji | J19.957E | |
| EPA CompTox Dashboard | DTXSID4023335 | |
| DrugCentral | 1842 | |
| ChemicalBook | CB4493310 | |
| Guide to Pharmacology | 7244 | |
| rxnorm | MORICIZINE | MORICIZINE HYDROCHLORIDE |
| KEGG Ligand | C07743 | |
| ChEBI | 6997 | |
| ZINC | ZINC000019340795 |
